Personalized Site-Specific Immunomodulation

The invention provides methods of treating inflammation in a specific organ or tissue of an individual. The method involves determining whether the individual has previously been infected with at least one pathogen that is pathogenic in the specific organ or tissue; and administering to the individu...

Full description

Saved in:
Bibliographic Details
Main Authors PREMACK BRETT ANTHONY, GUNN HAROLD DAVID, CHOW MICHAEL TAK HUAI, DHANJI SALIM
Format Patent
LanguageEnglish
Published 27.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides methods of treating inflammation in a specific organ or tissue of an individual. The method involves determining whether the individual has previously been infected with at least one pathogen that is pathogenic in the specific organ or tissue; and administering to the individual an anti-inflammatory composition comprising antigenic determinants, the antigenic determinants selected or formulated so that together they are specific for the at least one pathogen. The pathogen may be an endogenous or exogenous pathogen, and may further be a bacterial pathogen, a viral pathogen, a fungal pathogen, a protozoan pathogen, or a helminth pathogen.
Bibliography:Application Number: US201514632726